Screener
Aquestive Therapeutics, Inc. AQST Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount?
- Aquestive Therapeutics, Inc. (AQST) reported operating lease liability - undiscounted excess amount of $7.89M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount increased by 149.2% year-over-year, from $3.17M to $7.89M.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.
Ask your AI about Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude